219 related articles for article (PubMed ID: 27698389)
1. Aldo-keto reductase 1C1 induced by interleukin-1β mediates the invasive potential and drug resistance of metastatic bladder cancer cells.
Matsumoto R; Tsuda M; Yoshida K; Tanino M; Kimura T; Nishihara H; Abe T; Shinohara N; Nonomura K; Tanaka S
Sci Rep; 2016 Oct; 6():34625. PubMed ID: 27698389
[TBL] [Abstract][Full Text] [Related]
2. AKR1C1 Activates STAT3 to Promote the Metastasis of Non-Small Cell Lung Cancer.
Zhu H; Chang LL; Yan FJ; Hu Y; Zeng CM; Zhou TY; Yuan T; Ying MD; Cao J; He QJ; Yang B
Theranostics; 2018; 8(3):676-692. PubMed ID: 29344298
[TBL] [Abstract][Full Text] [Related]
3. Pathophysiological roles of aldo-keto reductases (AKR1C1 and AKR1C3) in development of cisplatin resistance in human colon cancers.
Matsunaga T; Hojo A; Yamane Y; Endo S; El-Kabbani O; Hara A
Chem Biol Interact; 2013 Feb; 202(1-3):234-42. PubMed ID: 23165153
[TBL] [Abstract][Full Text] [Related]
4. Slug contributes to cadherin switch and malignant progression in muscle-invasive bladder cancer development.
Wu K; Zeng J; Zhou J; Fan J; Chen Y; Wang Z; Zhang T; Wang X; He D
Urol Oncol; 2013 Nov; 31(8):1751-60. PubMed ID: 22421353
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1β regulates progesterone metabolism in human cervical fibroblasts.
Roberson AE; Hyatt K; Kenkel C; Hanson K; Myers DA
Reprod Sci; 2012 Mar; 19(3):271-81. PubMed ID: 22064385
[TBL] [Abstract][Full Text] [Related]
6. The roles of AKR1C1 and AKR1C2 in ethyl-3,4-dihydroxybenzoate induced esophageal squamous cell carcinoma cell death.
Li W; Hou G; Zhou D; Lou X; Xu Y; Liu S; Zhao X
Oncotarget; 2016 Apr; 7(16):21542-55. PubMed ID: 26934124
[TBL] [Abstract][Full Text] [Related]
7. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of aldo-keto reductase 1C1 in HT29 human colon cancer cells resistant to methotrexate: role in the cell cycle and apoptosis.
Selga E; Noé V; Ciudad CJ
Biochem Pharmacol; 2008 Jan; 75(2):414-26. PubMed ID: 17945194
[TBL] [Abstract][Full Text] [Related]
9. Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin.
Wang HW; Lin CP; Chiu JH; Chow KC; Kuo KT; Lin CS; Wang LS
Int J Cancer; 2007 May; 120(9):2019-27. PubMed ID: 17266043
[TBL] [Abstract][Full Text] [Related]
10. AKR1C1 Contributes to Cervical Cancer Progression via Regulating TWIST1 Expression.
Wei X; Wei Z; Li Y; Tan Z; Lin C
Biochem Genet; 2021 Apr; 59(2):516-530. PubMed ID: 33170398
[TBL] [Abstract][Full Text] [Related]
11. Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases.
Mahmud Z; Asaduzzaman M; Kumar U; Masrour N; Jugov R; Coombes RC; Shousha S; Hu Y; Lam EW; Yagüe E
Biochem Pharmacol; 2019 May; 163():391-403. PubMed ID: 30862505
[TBL] [Abstract][Full Text] [Related]
12. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
13. A novel role of Id-1 in regulation of epithelial-to-mesenchymal transition in bladder cancer.
Hu H; Wang YL; Wang GW; Wong YC; Wang XF; Wang Y; Xu KX
Urol Oncol; 2013 Oct; 31(7):1242-53. PubMed ID: 22226665
[TBL] [Abstract][Full Text] [Related]
14. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis.
Roth B; Jayaratna I; Sundi D; Cheng T; Melquist J; Choi W; Porten S; Nitti G; Navai N; Wszolek M; Guo C; Czerniak B; McConkey D; Dinney C
Oncotarget; 2017 May; 8(21):34205-34222. PubMed ID: 27494900
[TBL] [Abstract][Full Text] [Related]
15. The SIRT2-mediated deacetylation of AKR1C1 is required for suppressing its pro-metastasis function in Non-Small Cell Lung Cancer.
Zhu H; Hu Y; Zeng C; Chang L; Ge F; Wang W; Yan F; Zhao Q; Cao J; Ying M; Gu Y; Zheng L; He Q; Yang B
Theranostics; 2020; 10(5):2188-2200. PubMed ID: 32104503
[TBL] [Abstract][Full Text] [Related]
16. A novel role of ribonuclease inhibitor in regulation of epithelial-to-mesenchymal transition and ILK signaling pathway in bladder cancer cells.
Yao X; Li D; Xiong DM; Li L; Jiang R; Chen JX
Cell Tissue Res; 2013 Sep; 353(3):409-23. PubMed ID: 23703635
[TBL] [Abstract][Full Text] [Related]
17. Exosomes containing ErbB2/CRK induce vascular growth in premetastatic niches and promote metastasis of bladder cancer.
Yoshida K; Tsuda M; Matsumoto R; Semba S; Wang L; Sugino H; Tanino M; Kondo T; Tanabe K; Tanaka S
Cancer Sci; 2019 Jul; 110(7):2119-2132. PubMed ID: 31141251
[TBL] [Abstract][Full Text] [Related]
18. Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1.
Zhang Y; Liu W; He W; Zhang Y; Deng X; Ma Y; Zeng J; Kou B
Int J Oncol; 2016 May; 48(5):2035-42. PubMed ID: 26983576
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of AKR1C1 in mesenchymal stromal cells promotes the survival of acute myeloid leukaemia cells.
Jiang Y; Li Y; Cheng J; Ma J; Li Q; Pang T
Br J Haematol; 2020 May; 189(4):694-706. PubMed ID: 31943135
[TBL] [Abstract][Full Text] [Related]
20. Down-regulating ribonuclease inhibitor enhances metastasis of bladder cancer cells through regulating epithelial-mesenchymal transition and ILK signaling pathway.
Xiong D; Liou Y; Shu J; Li D; Zhang L; Chen J
Exp Mol Pathol; 2014 Jun; 96(3):411-21. PubMed ID: 24768914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
